What Is Pharmaceutical Warehousing and Why Does It Need Specialist Facilities?

A pallet of tablets and a pallet of tinned food take up the same floor space. Almost nothing else about how they are stored is the same.

Pharmaceutical warehousing is the licensed, controlled storage of medicinal products, active substances and healthcare goods under conditions that preserve their quality, safety and traceability from goods-in through to despatch. In the UK it sits under the EU Guidelines on Good Distribution Practice (2013/C 343/01), retained in UK law and enforced by the MHRA through the Wholesale Dealer's Authorisation for human medicines, the WDA(H).

A building alone is not a pharmaceutical warehouse. The licence, the people named on it, the qualification of the storage conditions and the records proving those conditions held are what make it one. Buyers evaluating a storage partner should assess those things, not the square footage.

Why a general warehouse cannot simply take on medicines

A general distribution centre optimises for throughput and cost per pallet move. A pharmaceutical warehouse optimises for those too, but only within constraints that come first: defined storage conditions, physical and system segregation of stock by status, control over who can touch what, and an audit trail that lets you reconstruct the history of any batch years later. Those constraints change the racking, the alarms, the procedures and the staffing.

The licence and the Responsible Person

Storage and distribution of licensed medicines in the UK requires a WDA(H). The authorisation names the site, the categories of product covered and at least one Responsible Person.

The RP is not an administrative title. The role carries personal, legal responsibility for ensuring the quality system operates, that product comes only from authorised suppliers, that only authorised customers are supplied, that returns and recalls are handled correctly, and that deviations are investigated. An RP has the standing to stop stock going out. When you audit a warehouse, ask to meet the RP and ask how often they have used that authority.

Where a site also manufactures or packs, it needs a Manufacturer's / Importer's Authorisation as well. GMP governs manufacture and packing up to and including QP certification; GDP governs storage and distribution after release. Central Pharma's Bedford site holds an MHRA MIA and an MHRA WDA(H), alongside an MHRA API storage licence for active pharmaceutical ingredients, which are licensed separately from finished medicinal products.

Qualifying and monitoring the storage envelope

Temperature mapping

You cannot claim a warehouse holds 15 to 25°C because the thermostat says so. The storage envelope has to be mapped: sensors distributed through the racking at high and low levels, near doors, loading bays, roof spaces and heat sources, recording long enough to capture normal operation and worst case conditions. Mapping is typically repeated for summer and winter, and again after any change that could alter airflow.

Mapping produces the evidence base for two decisions: where the permanent monitoring sensors go, and which locations suit which products. Hot and cold spots are either excluded from use or managed with defined restrictions.

Continuous monitoring, alarms and escalation

Once mapped, conditions are monitored continuously by calibrated sensors on a documented calibration schedule traceable to national standards, with data recorded, retained and reviewable.

What separates a serious operation from a nominal one is what happens at 02:00 on a Sunday. Alarms need defined thresholds and recipients, an out-of-hours escalation chain and a tested response procedure covering who attends site, what corrective action is available and how the excursion is assessed against stability data. An alarm nobody is contracted to answer is a record-keeping exercise, not a control.

Segregation by stock status

Every unit in a pharmaceutical warehouse has a status, and each status needs a defined location and system control:

• Quarantine for goods received and awaiting checks or release.
• Released stock available for picking.
• Rejected stock, held securely pending destruction or return.
• Returned stock, quarantined pending an RP assessment of whether it can re-enter saleable inventory.
• Recalled stock, segregated immediately and reconciled against distribution records.

Warehouse management system status flags do much of the work, but physical separation remains the expectation for rejected, recalled and returned material. A falsified medicines suspicion triggers immediate segregation and notification to the MHRA and the marketing authorisation holder.

Controlled drugs and secure areas

Controlled drugs fall under the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations 2001, with substances classified in Schedules 1 to 5. A Home Office licence is required for Schedule 1 and for certain activities across Schedules 2 to 4.

Safe custody obligations under the Misuse of Drugs (Safe Custody) Regulations 1973 specify approved safes, cabinets or rooms, and Home Office security guidance addresses construction standards, alarms, CCTV and access control. Operationally that means restricted keyholder lists, CD register entries, balance checks and witnessed destruction. Central Pharma holds a Home Office licence covering Schedule 1 to 5 and provides Schedule 1 to 5 storage and supply at Bedford.

Housekeeping, access and security

Pest control needs a documented programme with stations mapped, inspection frequencies set and trend data reviewed rather than filed. Cleaning follows written schedules with records, and the building fabric is maintained so the envelope stays sealed.

Access control is layered: site perimeter, warehouse, then higher-security areas for controlled drugs and high-value stock. Visitor logging, CCTV over goods-in, goods-out and secure areas, and intruder alarms all support the wider obligation to keep falsified product out of the legitimate supply chain.

Receipt, supplier qualification and traceability

Goods-in is the highest-value control point in the operation. Receipt checks confirm the delivery against the purchase order, verify the supplier is qualified and appropriately authorised, review transport conditions and in-transit temperature data, inspect for damage and tampering, and confirm batch numbers and expiry dates before anything is put away.

From that point, stock rotates on FEFO, first expired first out, rather than simple first in first out. Batch and expiry data is held at location level so a recall can be executed by batch across every pallet, pick face and customer despatch.

Scale, racking and layout

Scale determines whether a partner can hold your product in the right conditions without compromise. Pallet location count, the ratio of ambient to cold chain capacity, racking type, aisle width and the balance of bulk versus pick face locations all affect what a site can realistically accept.

Central Pharma operates a 267,000 sq ft Bedford site with more than 10,000 pallet storage locations, temperature-controlled warehousing, ambient storage, +2°C to +8°C refrigerated storage and freezer capacity at −20°C.

The documentation trail

Specialist pharmaceutical warehousing leaves a record of every action: goods-in checks, put-away, temperature data, cleaning, pest control, calibration certificates, training records, deviation and CAPA files, self-inspection reports and destruction certificates. An MHRA inspector will ask for those records. So should you, during a supplier audit.

Key takeaways

• Pharmaceutical warehousing is defined by the WDA(H) licence, the named Responsible Person and the quality system, not by building size.
• Storage conditions must be mapped and qualified before they can be claimed, then monitored continuously with alarms and a tested out-of-hours escalation route.
• Stock status segregation across quarantine, released, rejected, returned and recalled material is a core GDP requirement with both physical and system controls.
• Controlled drugs require a Home Office licence, safe custody compliant storage and register-based reconciliation.
• FEFO rotation with batch and expiry traceability at location level is what makes a recall executable rather than theoretical.

Talk to Central Pharma about pharmaceutical warehousing
Central Pharma has provided licensed storage and specialised logistics from Bedford since 2006: 267,000 sq ft, 10,000+ pallet locations, temperature-controlled warehousing, Schedule 1 to 5 controlled drug storage and an MHRA API storage licence, backed by MIA and WDA(H) authorisations, ISO 9001 and ISO 13485 certification and a dedicated QA team. To discuss your storage requirement, get in touch.

To stay informed on our latest thinking and technology developments, follow us on LinkedIn.

Contact Us Today

View all news